medi weight loss tirzepatide Injections Refined wellness. Elevated weight-loss. Restorative

The active ingredient in Mounjaro is tirzepatide, which works by mimicking two naturally occurring hormones in your body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)

#BiologicsManufacturing #PeptideDevelopment #MicrobialManufacturing #GLP1Innovation #DrugSubstance #GMPManufacturing

VICTOZA is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Separately, TRANSCEND-T2D-1 part of a distinct three-trial diabetes-specific program confirmed -2.0% HbA1c reduction and 16.8% weight loss in 537 type 2 diabetes patients (topline March 2026, published in The Lancet, June 2026)

48,58 No safety concerns were identified, and dose adjustment was not warranted in subjects with renal or hepatic impairment

Feb 2010;5(2):299-306